"Full House" star Dave Coulier revealed this week that he is cancer-free after undergoing chemotherapy following a diagnosis ...

Discover how innovative lymphoma treatments are transforming patient outcomes, from targeted therapies to immunotherapy ...

On Monday, Coulier's "Full House" co-star Candace Cameron Bure shared a celebratory message on Instagram regarding Coulier's ...

Dave Coulier, best known for Full House, recently opened up about his battle with stage 3 non-Hodgkin’s lymphoma in an ...

He originally got the diagnosis in October 2024. “(My doctors) said, ‘Hey, we wish we had better news, but you have ...

In a new interview, Dave Coulier revealed he was recently hospitalized for several days after catching a cold. He said his doctors told him if he had come in later, they might not have been able to ...

Background: Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma is a rare, indolent subtype of non-Hodgkin lymphoma ...

Just months after revealing he had been diagnosed with an advanced form of cancer, "Full House" actor Dave Coulier is ...

Less than a year after purchasing private cell therapy company ImmPact Bio to help refresh its ailing CAR-T pipeline, ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...

Researchers with City of Hope and MSK have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) ...

clonoSEQ testing for patients with MCL is currently available for clinical use as a laboratory-developed test performed at Adaptive's CLIA-certified lab in Seattle. clonoSEQ testing in MCL has also ...